Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 1248Terminated 228Active not recruiting 176Recruiting 162Unknown 123Withdrawn 87Not yet recruiting 32Suspended 4Enrolling by invitation 3

Sponsor Class

OTHER 356INDUSTRY 45OTHER_GOV 11NETWORK 3NIH 2FED 2UNKNOWN 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Localized Advanced Rectal Adenocarcinoma 1Head and Neck Neoplasms 1

Interventions

sintilimab 1Maintenance 1Gastrointestinal Microbiome 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × NETWORK × Interventional × Clear all
NCT06773936 2026-05-06

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

SWOG Cancer Research Network

Phase 2 Enrolling by invitation
55 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07062354 2026-05-06

CAPT-HN

SWOG Cancer Research Network

Phase 2 Enrolling by invitation
50 enrolled
Head & Neck

Head and Neck Neoplasms

NCT06931808 2025-04-17

Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer

First Affiliated Hospital of Ningbo University

Phase 4 Enrolling by invitation
20 enrolled
Gastrointestinal

Localized Advanced Rectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡